MIST
Milestone Pharmaceuticals Inc
NASDAQ: MIST · HEALTHCARE · BIOTECHNOLOGY
$1.80
-1.10% today
Updated 2026-04-30
Market cap
$218.86M
P/E ratio
—
P/S ratio
141.57x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
WallStSmart proprietary scores
14
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-8.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$6.50
+261.11%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -8.34 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-12.79M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $5.00M | $1.00M | $0.00 | $1.55M | $1.55M |
| Net income | $-57.13M | $-59.69M | $-41.52M | $-63.06M | $-17.41M |
| EPS | — | — | — | — | $-0.75 |
| Free cash flow | $-52.74M | $-46.54M | $-28.88M | $-49.34M | $-12.79M |
| Profit margin | -1,142.68% | -5,968.50% | — | -4,078.78% | — |
Peer comparison
Smart narrative
Milestone Pharmaceuticals Inc trades at $1.80. Our Smart Value Score of 14/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -8.34, it sits in the distress. TTM revenue stands at $1.55M.
Frequently asked questions
What is Milestone Pharmaceuticals Inc's stock price?
Milestone Pharmaceuticals Inc (MIST) trades at $1.80.
Is Milestone Pharmaceuticals Inc overvalued?
Smart Value Score 14/100 (Grade F, Strong Sell).
What is the price target of Milestone Pharmaceuticals Inc (MIST)?
The analyst target price is $6.50, representing +261.1% upside from the current price of $1.80.
What is Milestone Pharmaceuticals Inc's revenue?
TTM revenue is $1.55M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-8.34 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio141.57x
ROE-229.60%
Beta0.69
50D MA$1.68
200D MA$1.88
Shares out0.12B
Float0.01B
Short ratio—
Avg volume2.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—